Bullfrog AI Holdings, Inc. (NASDAQ:BFRG) Short Interest Update

Bullfrog AI Holdings, Inc. (NASDAQ:BFRGGet Free Report) was the recipient of a significant increase in short interest during the month of January. As of January 15th, there was short interest totalling 256,400 shares, an increase of 140.3% from the December 31st total of 106,700 shares. Based on an average daily trading volume, of 164,600 shares, the days-to-cover ratio is currently 1.6 days. Currently, 4.1% of the company’s stock are sold short.

Institutional Inflows and Outflows

An institutional investor recently bought a new position in Bullfrog AI stock. XTX Topco Ltd bought a new stake in Bullfrog AI Holdings, Inc. (NASDAQ:BFRGFree Report) in the second quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund bought 18,580 shares of the company’s stock, valued at approximately $32,000. XTX Topco Ltd owned 0.24% of Bullfrog AI as of its most recent SEC filing. Institutional investors and hedge funds own 0.96% of the company’s stock.

Bullfrog AI Trading Up 1.5 %

NASDAQ BFRG traded up $0.04 on Friday, hitting $2.69. 193,078 shares of the stock traded hands, compared to its average volume of 450,114. The stock has a 50-day moving average of $2.24 and a 200 day moving average of $2.45. Bullfrog AI has a twelve month low of $1.43 and a twelve month high of $5.89. The company has a market capitalization of $23.43 million, a P/E ratio of -3.16 and a beta of 0.13.

Bullfrog AI (NASDAQ:BFRGGet Free Report) last announced its quarterly earnings data on Friday, November 8th. The company reported ($0.22) earnings per share (EPS) for the quarter.

Bullfrog AI Company Profile

(Get Free Report)

Bullfrog AI Holdings, Inc, through its subsidiaries, operates as a digital biopharmaceutical company that focuses on artificial intelligence and machine learning (AI/ML) driven analysis of data sets in medicine and healthcare in the United States. The company offers bfLEAP, an analytical AI/ML platform for the analysis of preclinical and/or clinical data.

Featured Articles

Receive News & Ratings for Bullfrog AI Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bullfrog AI and related companies with MarketBeat.com's FREE daily email newsletter.